Navigation Links
Carcinoid Cancer Foundation Sets Sights on Raising Awareness
Date:3/2/2009

New president/CEO announces timely goals for established foundation

WHITE PLAINS, N.Y., March 2 /PRNewswire/ -- Several high-profile cancers are infamous for being silent killers - but they are not the only cancers that catch victims by surprise. Carcinoid cancer can go undetected for many years. Over 90% of all carcinoid/neuroendocrine tumor (NET) patients are initially incorrectly diagnosed and treated for the wrong disease. Carcinoid cancers are frequently diagnosed accidentally.

Carcinoid and related neuroendocrine tumors (NETs) grow slowly and are found mostly in the gastrointestinal system, but can be in other body parts like the pancreas and lung. It usually takes many years before they cause symptoms. If the disease manifests in advanced stages, it can be deadly. Caught early, however, carcinoid cancer can often be managed or treated, an option not fully realized within the medical community or patient circles, according to Sharon Devereaux, the newly appointed president/CEO of the Carcinoid Cancer Foundation(TM) (CCF, http://www.carcinoid.org). Increasing awareness of this disease and opportunities for early detection are an integral part of the Carcinoid Cancer Foundation's mission, and Devereaux's initiatives include intensification of efforts to accomplish these goals.

"Carcinoid cancer occasionally creeps into the headlines, usually when some public figure is living with it or passes away," Devereaux says. "But that's where the news value ends because it's perceived as rare - 110,000 U.S. patients are experiencing carcinoid cancer today. However, new research and anecdotal evidence suggests that it's more widespread than is documented, yet it's tough to provide treatment because established opportunities for early-diagnostic testing don't exist."

Richard R.P. Warner, MD, Medical Director of CCF and one of the world's leading experts on these rare cancers, explains "that although a number of new drugs are being developed and tested, at present the only cure for carcinoid/NETs is dependent on early detection and surgery before these cancers have spread from their original site of origin."

The CCF is a non-profit organization that strives to encourage and support research, in addition to educating the general public and healthcare professionals, about carcinoid cancer and NETs. Recently, the CCF has drawn attention to its cause through its "Zebra Ball - Stars for Stripes" (http://www.thezebraball.com), an annual benefit event held at The Peninsula Chicago to support The Carcinoid Cancer Foundation(tm). This year's ball, so named because zebra stripes symbolize "camouflaged" conditions, featured the stories of carcinoid cancer patient Don Meyer, Northern State University's (Aberdeen, S.D.) basketball coach, and cancer survivor Kari Jones of Indianapolis. The gala coincided with Valentine's Day, which has been designated by Mayor Richard Daley as Carcinoid Cancer Awareness Day in Chicago.

For more information or to donate, visit http://www.carcinoid.org or http://www.firstgiving.com/carcinoid.

About the Carcinoid Cancer Foundation(TM)

The Carcinoid Cancer Foundation(TM) is a non-profit organization chartered by the State of New York in 1968 for the purpose of encouraging and supporting research and education on carcinoid and related neuroendocrine cancers.

Photo, Sharon Devereaux:

http://www.ereleases.com/pr/2009-SharonDevereaux.jpg

    Contact:

    Sharon Devereaux
    CEO/President, Carcinoid Cancer Foundation(TM)
    847-571-4628
    zebraball@gmail.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Carcinoid Cancer Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wine May Be Protective Against Esophageal Cancer
2. Drinking wine lowers risk of Barretts esophagus, precursor to nations fastest growing cancer
3. Kaiser Permanente Study Finds Drinking Wine May Lower Risk of Barretts Esophagus, Precursor to Nations Fastest Growing Cancer, Esophageal Cancer
4. UIC receives $3 million to study prostate cancer risk factors
5. Inspired Cancer Survivor Launches Customized Hair Replacement Techniques at Award-Winning Hair Salon
6. New Test May Mean Faster Breast Cancer Treatment
7. Men With BRCA Gene Mutations Unaware of Cancer Risks
8. Stay Dry tested to help men with incontinence problems from prostate cancer treatments
9. Local Gastroenterology Practice Gives Back to the Community During Colon Cancer Awareness Month
10. Komen Tulsa Affiliate Awards $420,000 to Local Organizations to Aid Breast Cancer Fight
11. Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... years, researchers from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could ... after surgery, though activity levels decline over time. The study, presented today at ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
(Date:7/20/2017)... NY, July 20, 2017 (PRWEB) , ... ... ... Nastel Technologies, a global provider of enterprise-grade IT operations analytics and application ... arm of one of world’s largest healthcare services providers. , According to ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended ... The adjustable beds used in such facilities are specially designed to accommodate patients with ... support. , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... a clinical-stage pharmaceutical company focused on the development of oral ... from the Israel Securities Authority to dual-list its common stock ... will commence trading on the TASE on July 12, 2017 ... of the Company, it is expected that Oramed will be ...
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
(Date:6/30/2017)... In vitro diagnostics market firm Kalorama Information ... least ten diagnostic companies have successfully completed financings.  The ... a loan facility.  The size of these financings ranged ... Information provides a monthly IVD Market Trends Report ... "Diagnostics deals ...
Breaking Medicine Technology: